3 Firms Steer BioPharma's Go-Public With Blank Check Co.

Biopharmaceutical company Immatics said Tuesday it will combine with blank check company Arya Sciences to create a publicly traded company with an expected market capitalization of roughly $634 million, in a...

Already a subscriber? Click here to view full article